Catalyst Wire Dossier Catalyst Wire Dossier

tolterodine SR

tolterodine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for tolterodine SR, covering 2019-12-02 to 2019-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH) [Phase 4]

See pricing